Analysis identifies distance-specific functional connectivity disruptions in MDD subtypes, suggesting implications for treatment.
Motivation: The differences between first-episode drug-naïve (FEDN) and recurrent major depressive disorder (RMDD) patients in the functional dysconnectivity and their association with neurotransmitter systems remain poorly understood. Goal(s): To investigate distance-specific alterations of functional connectivity (FC) and the relationship between functional dysconnectivity and neurotransmitter systems in MDD subtypes. Approach: We examined distance-dependent FC differences in a large cohort of 848 MDD patients and 794 controls, and integrated them with neurotransmitter density from a public PET dataset. Results: FEDN and RMDD showed distinct patterns of distance-dependent FC disruption, particularly in long-range connections, with specific correlations with serotonergic, GABAergic, and opioid systems. Impact: Functional dysconnectivity in MDD subtypes shows distinct distance-dependent patterns and specific correlations with neurotransmitter systems. These findings advance our understanding of subtype-specific pathophysiology and may guide the development of more precise therapeutic strategies for MDD.
No takes yet. Share an insight, caveat, or question.
Qian et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: